Wird geladen...

Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza

Secondary bacterial infections (SBIs) exacerbate influenza-associated disease and mortality. Antimicrobial agents can reduce the severity of SBIs, but many have limited efficacy or cause adverse effects. Thus, new treatment strategies are needed. Kinetic models describing the infection process can h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Pharmacokinet Pharmacodyn
1. Verfasser: Smith, Amber M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer US 2016
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5376398/
https://ncbi.nlm.nih.gov/pubmed/27679506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10928-016-9494-9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!